The bias toward doing something

Non-surgical aesthetics are marketed hard. There’s a device or an injectable for almost every concern that walks through the door — sagging skin, dull tone, fine lines, deep lines, a chin that has softened, a jaw that has blurred, cheeks that have lost their fullness. The industry has an answer for each of them, and most of those answers involve a 30-minute appointment, minimal downtime, and a credit card.

It’s easier to say yes to a small treatment than to a surgery. That’s true for the patient and, honestly, for the practice too. Non-surgical treatments are lower-risk, faster, and more repeatable than operations. They’re also, increasingly, how a lot of aesthetic practices make their money. That combination creates a strong pull toward doing something — almost anything — when a patient walks in with a concern.

But the right answer isn’t always the biggest intervention available. And it isn’t always the smallest one, either. Good practice means matching the treatment to the actual problem, which sometimes means an injectable, sometimes means a laser, sometimes means a surgical consultation instead, and sometimes means honestly telling a patient there’s nothing worth doing yet.

What non-surgical actually treats well

Non-surgical isn’t one thing. It’s a spectrum of tools, each with a specific job. Understanding what each does — and doesn’t do — is the starting point for any honest conversation.

  • Neurotoxin (Botox, Dysport, Xeomin — all purified botulinum toxin injections that temporarily relax muscles) works on dynamic wrinkles: the lines caused by repeated muscle contraction. Forehead lines, crow’s feet, the vertical “11s” between the brows. Predictable, well-studied, temporary — typically three to four months per treatment.
  • Dermal fillers (hyaluronic acid gels like Juvederm and Restylane, sold under many trade names) replace lost volume, augment the lips, and can add structural contour to the cheek, jawline, or chin. Effects last months to a year or more depending on the product and location.
  • Sculptra is a collagen-stimulating injectable — poly-L-lactic acid — that works gradually over several months. It’s used for broad volume replacement in the face and body, and its results build slowly rather than appearing the day of treatment.
  • Kybella is an injectable form of deoxycholic acid that dissolves small pockets of fat, most commonly under the chin. It requires a series of treatments and produces permanent fat loss in the treated area.
  • Morpheus8 combines microneedling with radiofrequency energy to remodel the deeper layers of the skin. It’s useful for skin quality, texture, and mild-to-moderate tightening, and typically requires several sessions.
  • Energy devices more broadly — EON (a touchless laser for fat reduction), SoftWave (unfocused shockwave for tissue remodeling), Avava (fractional laser for tone and texture), Vivace (radiofrequency microneedling), and various laser resurfacing platforms — each address specific problems: pigmentation, texture, scarring, laxity, or fat.

The list is long on purpose. This is not a menu of things to try — it’s a spectrum of tools, and part of what a good consultation does is identify which tool, if any, is the right one for a specific concern.

Where non-surgical stops delivering

The limits of non-surgical treatments are real, and they get glossed over more often than they should. Injectables and energy devices cannot lift significantly loose skin. They cannot reposition tissue that has descended. They cannot remove large volumes of excess fat. They cannot correct the structural changes that come with advanced aging of the face or body.

A “non-surgical facelift” is a marketing phrase. It is not a facelift. If your problem is a facelift problem, no combination of injectables and lasers is going to fix it.

Patients who come in expecting a non-invasive treatment to reverse advanced aging often leave disappointed — not because the technology failed, but because the technology was never capable of what was promised. The branding around some devices has gotten aggressive enough that patients arrive already convinced they’ve found a shortcut. The right thing to do is tell them the truth: this device is excellent at what it does, and what it does is not what you’re asking for.

The right time for surgery is when the problem is structural. When skin has lost its elasticity, when tissue has migrated south, when fat has settled in a place it won’t leave — those are problems that need structural solutions.

Injectables: different tools for different problems

Even within injectables, patients and practices routinely conflate the two main categories — and the conflation matters.

Neurotoxin freezes muscle movement. It works on dynamic lines: the lines that appear when you smile, frown, or raise your brows. If you look in the mirror at rest and see a smooth forehead, but the lines appear when you make an expression, neurotoxin is likely the right tool.

Filler adds volume. It works on static lines: the lines that are present at rest, etched into the skin regardless of expression. It also addresses volume loss — hollow cheeks, thin lips, a deflated tear trough, a chin that has receded with age.

These are not interchangeable. A patient with deep static forehead lines who gets neurotoxin will get partial improvement at best; the muscle stops moving, but the lines etched into the skin at rest don’t fully resolve. A patient with early muscle-driven crow’s feet doesn’t need filler under the eyes — neurotoxin will do the job with less risk and less cost. Getting this wrong is one of the most common ways patients end up spending money on treatments that don’t give them what they wanted.

Energy devices: what they can and can’t do

Modern energy devices — radiofrequency microneedling like Morpheus8 or Vivace, fractional laser resurfacing, focused ultrasound and shockwave platforms — work by controlled injury. They stimulate collagen production and remodel tissue over the weeks and months after treatment. In the right patient with the right concern, they produce real improvement in skin quality, texture, tone, and mild-to-moderate laxity.

They are not, however, a substitute for a facelift when the underlying problem is structural aging. Skin that has lost significant elasticity will not retract to a taut, youthful position because a device warmed it up. A jowl that has formed because the fat pad has descended will not migrate back to its original location because the overlying skin was needled.

Some other things worth knowing before booking energy-device treatments:

  • Multiple sessions are almost always required. Single-treatment marketing is rarely honest about the full protocol.
  • Downtime varies significantly. Some radiofrequency treatments have essentially none. Aggressive laser resurfacing can require a week or more of visible healing.
  • Results build over months. If you’re expecting to look different at your event next Saturday, you’re expecting the wrong thing.
  • Skin type matters. Some devices carry higher pigmentation risk for patients with darker skin tones, and this should be discussed openly before treatment, not after.

When you know it’s time for surgery

There are signs the non-surgical route is being oversold to you — or being sold to you longer than it should be. Watch for:

  • Heavy jowls that don’t respond to skin tightening. If a device has been recommended and the second, third, fourth round of treatment isn’t producing a visible change, the problem is likely structural.
  • Loose neck skin that doesn’t retract. The neck is notorious for this. Non-surgical tightening has its ceiling, and past it, the answer is a neck lift or a lower facelift.
  • Breast tissue that has descended below the inframammary fold. No device or injectable lifts breasts. If the nipple sits below the crease, a lift is the operation that addresses it.
  • Abdominal skin that has lost its elasticity from pregnancy or significant weight change. Radiofrequency treatments can improve texture and give modest tightening. They cannot recreate the abdominal wall or remove excess skin.

These are structural problems. Continued non-surgical treatment for a structural problem often just delays a decision that would have been better made two years ago — and the money spent in between can equal or exceed the cost of the operation that was needed all along.

The most expensive treatment plan is often the one that keeps postponing the right one.

The rare wisdom of doing less

The other direction matters just as much. Not every concern needs a treatment. Not every treatment produces a meaningful improvement. Some of the best consultations I have end with the patient not scheduling anything — because the honest answer is that what’s bothering them isn’t bad enough to warrant intervention, or because the improvement they’d get isn’t worth the cost, the recovery, or the small but real risk of a bad outcome.

The right answer is sometimes “not yet.” The right answer is sometimes “not at all.” The right answer is sometimes “wait a year and let’s see how you feel about it then.” That kind of restraint is quieter than a new device launch, but it’s what good judgment sounds like in aesthetic medicine.

The best aesthetic practices know how to talk patients out of things — not because they don’t value the business, but because they value the outcome more. A treatment that leaves a patient looking overdone, artificially frozen, or subtly different in a way that they can’t put words to is worse than no treatment at all. The bar isn’t whether we can do something. The bar is whether doing it will make a difference the patient will genuinely be glad about.

That’s the whole game. Match the tool to the problem. Say no when there isn’t a good tool. Recommend surgery when the problem needs it. Recommend nothing when nothing is what’s called for. The patients who leave a consultation with less than they came in expecting are often the ones who come back years later for something that actually mattered — because they remembered being told the truth the first time.